The aim of this study was to apply the antibodies for marker of EMT vimentin and markers of pluripotency NANOG, SOX2 and SSEA-4 to ovarian tumor sections of women with epithelial cancer, and focus on morphological changes in the ovarian surface epithelium. The gene discussed is VIM; the disease is ovarian neoplasm.